Sign in
4

Changes in Ownership

ENDRA Life Sciences Inc. Filed Acc 0001209191-18-040509

Options or other derivatives

  • Chief Financial Officer acquired 2,480 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Wells David R. · Chief Financial Officer

Table II: Derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2018-06-28 Grant or award : show line 1 in the form Convertible Promissory Note +0 $10,000.00 $0 I
2018-06-28 Grant or award : show line 2 in the form Warrants +2,480 2,480 I
Loading xslF345X03/doc4.xml…